Erythropoietin improves histological and functional outcomes after traumatic brain injury in mice in the absence of the neural erythropoietin receptor

Journal of Neurotrauma

Volumn 27, Issue 1, 2010, Pages 205-215

  Xiong, Ye ^a   Mahmood, Asim ^a   Qu, Changsheng ^a   Kazmi, Humaira ^a   Zhang, Zheng Gang ^b   Noguchi, Constance T ^c   Schallert, Timothy ^d   Chopp, Michael ^b,e  

^a Department of Neurosurgery ^*  (United States)

^b HENRY FORD HOSPITAL   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^e OAKLAND UNIVERSITY   (United States)

Author keywords

Erythropoietin receptor null; Mouse; Sensorimotor; Spatial learning; Traumatic brain injury

Indexed keywords

ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; PROTEIN BCL XL; PROTEIN KINASE B;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN PROTECTION; CELL DENSITY; CONTROLLED STUDY; DENTATE GYRUS; EPOR GENE; FEMALE; HIPPOCAMPUS; HISTOPATHOLOGY; LEARNING; MAZE TEST; MOUSE; NEUROPROTECTION; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; SENSORIMOTOR FUNCTION; SPATIAL MEMORY; TRAUMATIC BRAIN INJURY; WESTERN BLOTTING;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; BRAIN; BRAIN INJURIES; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN; FEMALE; HIPPOCAMPUS; HUMANS; MEMORY DISORDERS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; PROMOTER REGIONS, GENETIC; RECEPTORS, ERYTHROPOIETIN; TREATMENT OUTCOME;

EID: 76349118106     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2009.1001     Document Type: Article

References (51)

1. Baskin, Y.K., Dietrich, W.D., and Green, E.J. (2003). Two effective behavioral tasks for evaluating sensorimotor dysfunction following traumatic brain injury in mice. J. Neurosci. Methods 129, 87-93.
2. Brines, M.L., Ghezzi, P., Keenan, S., Agnello, D., de Lanerolle, N.C., Cerami, C., Itri, L.M., and Cerami. A. (2000). Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. U.S.A. 97, 10526-10531.
3. Chang, Y.S., Mu, D., Wendland, M., Sheldon, R.A., Vexler, Z.S., McQuillen, P.S., and Ferriero, D.M. (2005). Erythropoietin improves functional and histological outcome in neonatal stroke. Pediatr. Res. 58, 106-111.
4. Chen, J., Zhang, C., Jiang, H., Li, Y., Zhang, L., Robin, A., Katakowski, M., Lu, M., and Chopp, M. (2005). Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice. J. Cereb. Blood Flow Metab. 25, 281-290.
5. Chen, Z.Y., Asavaritikrai, P., Prchal, J.T., and Noguchi, C.T. (2007). Endogenous erythropoietin signaling is required for normal neural progenitor cell proliferation. J. Biol. Chem. 282, 25875-25883.
6. Cherian, L., Goodman, J.C., and Robertson, C. (2007). Neuroprotection with erythropoietin administration following controlled cortical impact injury in rats. J. Pharmacol. Exp. Ther. 322, 789-794.
7. Chi, O.Z., Hunter, C., Liu, X., and Weiss, H.R. (2008). Effects of erythropoietin on blood-brain barrier disruption in focal cerebral ischemia. Pharmacology 82, 38-42.
8. Choi, S.H., Woodlee, M.T., Hong, J.J., and Schallert, T. (2006). A simple modification of the water maze test to enhance daily detection of spatial memory in rats and mice. J. Neurosci. Methods 156, 182-193.
9. di Villa Bianca, R., Sorrentino, R., Mitidieri, E., Marzocco, S., Autore, G., Thiemermann, C., and Pinto, A. (2009). Recombinant human erythropoietin prevents lipopolysaccharide-induced vascular hyporeactivity in the rat. Shock 31, 529-534.
10. Ehrenreich, H., Hasselblatt, M., Dembowski, C., Cepek, L., Lewczuk, P., Stiefel, M., Rustenbeck, H.H., Breiter, N., Jacob, S., Knerlich, F., Bohn, M., Poser, W., Ruther, E., Kochen, M., Gefeller, O., Gleiter, C., Wessel, T.C., De Ryck, M., Itri, L., Prange, H., Cerami, A., Brines, M., and Siren, A.L. (2002). Erythropoietin therapy for acute stroke is both safe and beneficial. Mol. Med. 8, 495-505.
11. Gonzalez, F.F., McQuillen, P., Mu, D., Chang, Y., Wendland, M., Vexler, Z., and Ferriero, D.M. (2007). Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke. Dev. Neurosci. 29, 321-330.
12. Grasso, G., Sfacteria, A., Cerami, A., and Brines, M. (2004). Erythropoietin as a tissue-protective cytokine in brain injury: what do we know and where do we go? Neuroscientist 10, 93-98.
13. Grasso, G., Sfacteria, A., Meli, F., Fodale, V., Buemi, M., and Iacopino, D.G. (2007). Neuroprotection by erythropoietin administration after experimental traumatic brain injury. Brain Res. 1182, 99-105.
14. Hartley, C.E., Varma, M., Fischer, J.P, Riccardi, R., Strauss, J.A., Shah, S., Zhang, S., and Yang, Z.J. (2008). Neuroprotective effects of erythropoietin on acute metabolic and pathological changes in experimentally induced neurotrauma. J. Neurosurg. 109, 708-714.
15. Iwai, M., Cao, G., Yin, W., Stetler, R.A., Liu, J., and Chen, J. (2007). Erythropoietin promotes neuronal replacement through revascularization and neurogenesis after neonatal hypoxia= ischemia in rats. Stroke 38, 2795-2803.
16. Jelkmann, W. (2000). Use of recombinant human erythropoietin as an antianemic and performance enhancing drug. Curr. Pharm. Biotechnol. 1, 11-31.
17. Keogh, C.L., Yu, S.P., and Wei, L. (2007). The effect of recombinant human erythropoietin on neurovasculature repair after focal ischemic stroke in neonatal rats. J. Pharmacol. Exp. Ther. 322, 521-528.
18. Langlois, J.A., Rutland-Brown, W., and Wald, M.M., (2006). The epidemiology and impact of traumatic brain injury: a brief overview. J. Head Trauma Rehabil. 21, 375-378.
19. Liao, Z.B., Zhi, X.G., Shi, Q.H., and He, Z.H. (2008). Recombinant human erythropoietin administration protects cortical neurons from traumatic brain injury in rats. Eur. J. Neurol. 15, 140-149.
20. Li, Y., Lu, Z., Keogh, C.L., Yu, S.P., and Wei, L. (2007). Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice. J. Cereb. Blood Flow Metab. 27, 1043-1054.
21. Lu, D., Mahmood, A., Qu, C., Goussev, A., Schallert, T., and Chopp, M. (2005). Erythropoietin enhances neurogenesis and restores spatial memory in rats after traumatic brain injury. J. Neurotrauma. 22, 1011-1017.
22. Marti, H.H. (2004). Erythropoietin and the hypoxic brain. J. Exp. Biol. 207, 3233-3242.
23. Minambres, E., Ballesteros, M.A., Mayorga, M., Marin, M.J., Munoz, P., Figols, J., and Lopez-Hoyos, M. (2008). Cerebral apoptosis in severe traumatic brain injury patients: an in vitro, in vivo, and postmortem study. J. Neurotrauma 25, 581-591.
24. Mogensen, J., Jensen, C., Kingod, S.C., Hansen, A., Larsen, J.A., and Mala, H. (2008). Erythropoietin improves spatial delayed alternation in a T-maze in fimbria-fornix transected rats. Behav. Brain Res. 186, 215-221.
25. Naranda, T., Kaufman, R.I., Li, J., Wong, K., Boge, A., Hallen, D., Fung, K.Y., Duncan, M.W., Andersen, N., Goldstein, A., and Olsson, L. (2002). Activation of erythropoietin receptor through a novel extracellular binding site. Endocrinology 143, 2293-2302.
26. Narayan, R.K., Michel, M.E., Ansell, B., Baethmann, A., Biegon, A., Bracken, M.B., Bullock, M.R., Choi, S.C., Clifton, G.L., Contant, C.F., Coplin, W.M., Dietrich, W.D., Ghajar, J., Grady, S.M., Grossman, R.G., Hall, E.D., Heetderks, W., Hovda, D.A., Jallo, J., Katz, R.L., Knoller, N., Kochanek, P.M., Maas, A.I., Majde, J., Marion, D.W., Marmarou, A., Marshall, L.F., Mc-Intosh, T.K., Miller, E., Mohberg, N., Muizelaar, J.P., Pitts, L.H., Quinn, P., Riesenfeld, G., Robertson, C.S., Strauss, K.I., Teasdale, G., Temkin, N., Tuma, R., Wade, C., Walker, M.D., Weinrich, M., Whyte, J., Wilberger, J., Young, A.B., and Yurkewicz, L. (2002). Clinical trials in head injury. J. Neurotrauma 19, 503-557.
27. Noguchi, C.T., Wang, L., Rogers, H.M., Teng, R., and Jia, Y. (2008). Survival and proliferative roles of erythropoietin beyond the erythroid lineage. Expert Rev. Mol. Med. 10, e36.
28. Noshita, N., Lewen, A., Sugawara, T., and Chan, P.H. (2002). Akt phosphorylation and neuronal survival after traumatic brain injury in mice. Neurobiol. Dis. 9, 294-304.
29. Pun, P.B., Lu, J., and Moochhala, S. (2009). Involvement of ROS in BBB dysfunction. Free Radic. Res. 43, 348-364.
30. Royo, N.C., Shimizu, S., Schouten, J.W., Stover, J.F., and McIntosh, T.K. (2003). Pharmacology of traumatic brain injury. Curr. Opin. Pharmacol. 3, 27-32.
31. Ruscher, K., Freyer, D., Karsch, M., Isaev, N., Megow, D., Sawitzki, B., Priller, J., Dirnagl, U., and Meisel, A. (2002). Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J. Neurosci. 22, 10291-10301.
32. Sakanaka, M., Wen, T.C., Matsuda, S., Masuda, S., Morishita, E., Nagao, M., and Sasaki, R. (1998). In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl. Acad. Sci. U.S.A. 95, 4635-4640.
33. Shafi, N.I., Andresen, J., Marrelli, S.P., and Bryan, R.M., Jr. (2008). Erythropoietin potentiates EDHF-mediated dilations in rat middle cerebral arteries. J. Neurotrauma 25, 257-265.
34. Spandou, E., Papadopoulou, Z., Soubasi, V., Karkavelas, G., Simeonidou, C., Pazaiti, A., and Guiba-Tziampiri, O. (2005). Erythropoietin prevents long-term sensorimotor deficits and brain injury following neonatal hypoxia-ischemia in rats. Brain Res. 1045, 22-30.
35. Strauss, K.I., Narayan, R.K., and Raghupathi, R. (2004). Common patterns of bcl-2 family gene expression in two traumatic brain injury models. Neurotox. Res. 6, 333-342.
36. van der Kooij, M.A., Groenendaal, F., Kavelaars, A., Heijnen, C.J., and van Bel, F. (2008). Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia=ischemia. Brain Res. Rev. 59, 22-33.
37. Verdonck, O., Lahrech, H., Francony, G., Carle, O., Farion, R., Van de Looij, Y., Remy, C., Segebarth, C., and Payen, J.F. (2007). Erythropoietin protects from post-traumatic edema in the rat brain. J. Cereb. Blood Flow Metab. 27, 1369-1376.
38. Wang, L., Zhang, Z., Wang, Y., Zhang, R., and Chopp, M. (2004). Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 35, 1732-1737.
39. Wang, Y., Zhang, Z.G., Rhodes, K., Renzi, M., Zhang, R.L., Kapke, A., Lu, M., Pool, C., Heavner, G., and Chopp, M. (2007). Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia. Br. J. Pharmacol. 151, 1377-1384.
40. Wojchowski, D.M., Gregory, R.C., Miller, C.P., Pandit, A.K., and Pircher, T.J. (1999). Signal transduction in the erythropoietin receptor system. Exp. Cell Res. 253, 143-156.
41. Wu, H., Lu, D., Jiang, H., Xiong, Y., Qu, C., Li, B., Mahmood, A., Zhou, D., and Chopp, M. (2008a). Increase in phosphorylation of Akt and its downstream signaling targets and suppression of apoptosis by simvastatin after traumatic brain injury. J. Neurosurg. 109, 691-698.
42. Wu, H., Lu, D., Jiang, H., Xiong, Y., Qu, C., Li, B., Mahmood, A., Zhou, D., and Chopp, M. (2008b). Simvastatin-mediated upregulation of VEGF and BDNF, activation of the PI3K=Akt pathway, and increase of neurogenesis are associated with therapeutic improvement after traumatic brain injury. J. Neurotrauma 25, 130-139.
43. Xiong, Y., Lu, D., Qu, C., Goussev, A., Schallert, T., Mahmood, A., and Chopp, M. (2008a). Effects of erythropoietin on reducing brain damage and improving functional outcome after traumatic brain injury in mice. J. Neurosurg. 109, 510-521.
44. Xiong, Y., Mahmood, A., Lu, D., Qu, C., Goussev, A., Schallert, T., and Chopp, M. (2007). Role of gender in outcome after traumatic brain injury and therapeutic effect of erythropoietin in mice. Brain Res. 1185, 301-312.
45. Xiong, Y., Mahmood, A., Lu, D., Qu, C., Kazmi, H., Goussev, A., Zhang, Z.G., Noguchi, C.T., Schallert, T., and Chopp, M. (2008b). Histological and functional outcomes after traumatic brain injury in mice null for the erythropoietin receptor in the central nervous system. Brain Res. 1230, 247-257.
46. Yatsiv, I., Grigoriadis, N., Simeonidou, C., Stahel, P.F., Schmidt, O.I., Alexandrovitch, A.G., Tsenter, J., and Shohami, E. (2005). Erythropoietin is neuroprotective, improves functional recovery, and reduces neuronal apoptosis and inflammation in a rodent model of experimental closed head injury. FASEB. J. 19, 1701-1703.
47. Yin, W., Cao, G., Johnnides, M.J., Signore, A.P., Luo, Y., Hickey, R.W., and Chen, J. (2006). TAT-mediated delivery of Bcl-xL protein is neuroprotective against neonatal hypoxic-ischemic brain injury via inhibition of caspases and AIF. Neurobiol. Dis. 21, 358-371.
48. Zhande, R., and Karsan, A. (2007). Erythropoietin promotes survival of primary human endothelial cells through PI3Kdependent, NF-kappaB-independent upregulation of Bcl-xL. Am. J. Physiol. Heart Circ. Physiol. 292, H2467-H2474.
49. Zhang, F., Signore, A.P., Zhou, Z., Wang, S., Cao, G., and Chen, J. (2006). Erythropoietin protects CA1 neurons against global cerebral ischemia in rat: potential signaling mechanisms. J. Neurosci. Res. 83, 1241-1251.
50. Zhang, J., Li, Y., Cui, Y., Chen, J., Lu, M., Elias, S.B., and Chopp, M. (2005). Erythropoietin treatment improves neurological functional recovery in EAE mice. Brain Res. 1034, 34-39.
51. Zhang, R., Wang, Y., Zhang, L., Zhang, Z., Tsang, W., Lu, M., Zhang, L., and Chopp, M. (2002). Sildenafil (Viagra) induces neurogenesis and promotes functional recovery after stroke in rats. Stroke 33, 2675-2680.